Your browser doesn't support javascript.
loading
[Drug treatment of Alzheimer's dementia : Status quo and perspectives]. / Pharmakologische Therapie der Alzheimer-Demenz : Aktueller Stand und Perspektiven.
Müller, P; Fendt, M; Müller, N G.
Afiliação
  • Müller P; AG Neuroprotektion, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Leipziger Str. 44, 39120, Magdeburg, Deutschland. patrick.mueller@dzne.de.
  • Fendt M; Institut für Pharmakologie und Toxikologie, Otto-von-Guericke-Universität, Magdeburg, Deutschland.
  • Müller NG; Center for Behavioural Brain Sciences (CBBS), Magdeburg, Deutschland.
Internist (Berl) ; 60(7): 761-768, 2019 Jul.
Article em De | MEDLINE | ID: mdl-31139854
ABSTRACT
Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system. AD is characterized by progressive impairments of memory as well as other cognitive functions and an increasing loss of autonomy in everyday life. This review article provides an overview of the current state-of-the-art (symptomatic) pharmacological treatment of Alzheimer's disease, specifics in the context of concomitant neuropsychiatric symptoms in multimorbid patients, and drugs currently under development that have a potentially causal (disease modifying) effect are also mentioned.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Memantina / Inibidores da Colinesterase / Doença de Alzheimer Limite: Humans Idioma: De Revista: Internist (Berl) Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Memantina / Inibidores da Colinesterase / Doença de Alzheimer Limite: Humans Idioma: De Revista: Internist (Berl) Ano de publicação: 2019 Tipo de documento: Article